Biomedical Archives - Blogs & Articles

An Overview of Spatial Transcriptomics: Techniques and Applications With Cátia Moutinho of GWCCG

August 18, 2021August 18, 2021 MarketsandMarkets Conferences

Dr. Cátia Moutinho is the Associate Director of Garvan-Weizmann Centre for Cellular Genomics, at the Garvan Institute Sydney-Australia. Also, she is the Group Leader of the Single Cell Technology Development Team. Her group focuses on single-cell genomics development. She is a biologist by training, with a PhD in Biomedicine and a master in Clinical Trials and Medical Affairs. She has an extensive experience in the wet-lab, with a strong background in single-cell technology, as well as cancer genetics and epigenetics. Cátia is also co-founder of the Single-Cell Ninjas Project, a…

Delve into the new era of genome sequencing- MarketsandMarkets Advanced Genetic Sequencing Virtual Conference

July 15, 2021 MarketsandMarkets Conferences

July 12th, 2021- Genome sequencing is providing physicians with more data about the causes of cancer and changing the way some forms of the disease are treated. Continued advancements in sequencing technologies have fuelled the development of new sequencing applications. MarketsandMarkets is proud to announce the first edition of Advanced Genetic Sequencing Virtual Conference scheduled to be held on 23rd & 24th of September 2021. A 2-day content-rich program combining stellar expertise from world-renowned keynote and featured speakers in the areas of Genetics & Genomics an expanding field of biology…

Discussing the latest IO developments at the 5th Annual MarketsandMarkets Next-Gen Immuno-Oncology Virtual Congress 2021

July 8, 2021July 29, 2021 MarketsandMarkets Conferences

July, 08th 2021 – 5th Annual MarketsandMarkets Next-Gen Immuno-Oncology Virtual Congress 2021 to be held on the 26th-29th October 2021 will host top tier institutes pharmaceutical, bio-pharmaceutical and biotechnology companies like Scancell, Regeneron Pharmaceuticals, Cancer Vaccines Ltd, Boston Immune Technologies & Therapeutics & more to deliver the key challenges and future directions in IO research and to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors The conference aims to bring together 25+ industry thought leaders & 200+ attendees from pharmaceutical and…

Héctor Pérez Montoyo, of Ability Pharma discusses his research on, “ABTL0812, a new immunotherapeutic anticancer agent at phase 2b clinical stage.”

June 3, 2021August 25, 2021 MarketsandMarkets Conferences

Héctor’s work has always focused on understanding the molecular pathophysiological mechanisms leading to autoimmunity and cancer development, investigating mechanism of action of newly developed molecules to treat such diseases. He started his career in 2006 when he moved to UT Southwestern Medical Center in Dallas (EEUU), to carry out this thesis in developing novel therapeutic antibodies in murine models of human autoimmune diseases. After obtaining his Ph.D., he combined two postdoctoral grants in Barcelona (Metastasis and Transformation group in Bellvitge Biomedical Research Center) and in Valencia (Autoimmune Pathology Lab in…

Dr. William Williams of Briacell Therapeutics Corporation talks about Personalized, off-the-shelf cellular immunotherapy for cancer

May 24, 2021 MarketsandMarkets Conferences

Dr. Williams is the President and CEO of BriaCell Corporation, where he has shepherded Bria-IMT™ into the clinic, established positive proof-of-concept, forged a collaboration with Incyte for novel combinations and coordinated the development of an off-the-shelf personalized approach to cancer immunotherapy. While at Incyte Corporation as Head of Exploratory Development, he brought numerous molecules into the clinic and established proof of concept in several disease areas. At GlaxoSmithKline he worked to bring several molecules into the clinic, ran a biomarker laboratory and spearheaded initiatives to utilize emerging technologies in drug…

Discussing Top 10 Disruptions in BioPharma Manufacturing at the MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT!

February 26, 2021 MarketsandMarkets Conferences

February 26th – MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT on the March 11, 2021 will hostindustry giants Fresenius Kabi, Charles River Laboratories, GenScript ProBio, Pall Corporation and MilliporeSigma to present their thoughts on the Top 10 Disruptions Through BioPharma Manufacturing in the next 5 year! MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT will gather 100+ professionals from industry giants such as Biocon Biologics, Ology Bioservices, Celonic AG, Gyroscope Therapeutics, GenIbet, Hemobras, H2i Group, MilliporeSigma, Orange Grove Bio, HORIBA, Porex Life Sciences Institute, Kaneka, Lonza, Cytiva, GEA North America, Batavia Biosciences, Nova…

Discussing ‘Reducing Errors at Point-Of-Care’ with Uchenna Okeahiala of Airedale and Bradford Hospitals Integrated Pathology Solutions, UK .

January 19, 2021 MarketsandMarkets Conferences

Graduated from University of Nigeria with a bachelor’s degree in Biomedical Sciences in 1989, Uchenna started her career as a Biomedical Scientist in Nigeria She relocated to the United Kingdom in 1991 where she obtained her Master’s degree in Biomedical Sciences from University of Cardiff with a Distinction in 1996 and went on to score a certificate in management from the Open University (1999). Later in 2006, she obtained a certificate in Extended Practice in Quality Management with Institute of Biomedical Sciences (IBMS). Since then has worked in various NHS…